Science. Hope. Solutions.

ReligenDX is dedicated to advancing the understanding and treatment of neurodevelopmental, neuropsychiatric and neurodegenerative disorders through innovative diagnostic testing. Our comprehensive suite of tests, including FRAT^®, MitoSwab^TM, MitoSeq^TM, and ReliExome^TM, provide valuable insights into the underlying genetic and metabolic factors contributing to neurodevelopmental, neuropsychiatric and neurodegenerative conditions.

Our comprehensive genetic testing services, including Whole Exome and Genome Sequencing, provide valuable insights into your unique genetic makeup. By identifying key genetic variations, we enable healthcare providers to deliver personalized care and targeted interventions, empowering you to take control of your health.

Our cutting-edge CholEffluX^TM test analyzes HDL function, providing a comprehensive assessment of cardio vascular risk factors. By identifying impairments in cholesterol efflux capacity, healthcare providers can develop targeted interventions to improve cardio vascular health outcomes.

ReligenDX is committed to advancing cancer diagnostics and personalized treatment strategies. Our state-of-the-art genetic testing solutions, such as sTRA, CA 19-9 and ReliExome^TM, help identify key biomarkers and genetic variations that can lead to targeted therapies and improve patient outcomes.